Loading organizations...
§ Private Profile · Blue Bell, PA, USA
Biotechnology company developing oncolytic immunotherapeutics for cancer.
Seneca Therapeutics has raised $4.1M across 2 funding rounds.
Seneca Therapeutics has raised $4.1M in total across 2 funding rounds.
Seneca Therapeutics has raised $4.1M across 2 funding rounds. Most recently, it raised $3.9M Series B Extension in August 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 28, 2025 | $3.9M Series B Plus | — | — | Announced |
| Jan 1, 2024 | $190K Venture Round | Keiretsu Capital | BEN Pidgeon | Announced |
Seneca Therapeutics has raised $4.1M in total across 2 funding rounds.
Seneca Therapeutics's investors include Keiretsu Capital, Ben Pidgeon.